DePuy Synthes, Smith & Nephew, Alphatec & more: 9 device company notes

Here are nine key notes on orthopedic and spine device companies from the past week.

Advertisement

In partnership with Wellframe, Smith & Nephew launched a digital platform to allow orthopedic surgeons to track their patients’ recovery progress and satisfaction.

 

The 7th U.S. Circuit Court of Appeals refused to reopen the lawsuit against Zimmer Biomet’s NexGen knee implants.

 

Alphatec named a new CEO, COO and CMO.

 

Alphatec acquired SafeOp Surgical, a privately held advanced neuromonitoring technology provider.

 

DePuy Synthes launched the ACTIS Total Hip System in the U.S. at the 2018 American Academy of Orthopaedic Surgeons Annual Meeting in New Orleans.

 

Life Spine announced the first clinical use of SENTRY 2 Lateral Plating System.

 

Global pediatric orthopedic company WishBone Medical entered into a license agreement with New York City-based Hospital for Special Surgery to develop a novel pediatric hip implant.

 

Globus Medical and Fovia entered a licensing and distribution agreement.

 

After its success the spine market, Globus Medical is now entering the orthopedic trauma market.

 

More articles on devices and implants:
5 things to know about Camber Spine CEO Daniel Pontecorvo
Smith & Nephew launch platform to engage patients, track surgical outcomes: 4 key points
Appeals court upholds Zimmer Biomet’s ‘win’ in NexGen knee implant case: 4 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new product launches and leadership appointments, here are seven key headlines from Stryker in the first quarter of 2026.…

  • Xtant Medical’s 2025 revenue reached $133.9 million, a 14% increase year over year, according to financial results posted March 31.…

Advertisement

Comments are closed.